Retension Pharmaceuticals Inc is a United States-based clinical-stage biopharmaceutical company. The Company is focused on developing treatments for hypertension and cardiovascular health. It is developing RTN-001 as a therapy for patients with hypertension. RTN-001 is a second generation inhibitor of phosphodiesterase type 5 (PDE5) for erectile dysfunction, preferentially distributes to cardiovascular tissues. more
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| RTSN | |
|---|---|
| ROA (LTM) | 0.00% |
| ROE (LTM) | 0.00% |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| RTSN | |
|---|---|
| Trailing PE | NM |
| Forward PE | NM |
| P/S (TTM) | 0.00 |
| P/B | 0.00 |
| EV/R | 0.00 |
| EV/Ebitda | NM |
Retension Pharmaceuticals (RTSN) share price today is $0
Yes, Indians can buy shares of Retension Pharmaceuticals (RTSN) on Vested. To buy
Yes, you can purchase fractional shares of Retension Pharmaceuticals (RTSN) via the Vested app. You can start investing in Retension Pharmaceuticals (RTSN) with a minimum investment of $1.
You can invest in shares of Retension Pharmaceuticals (RTSN) via Vested in three simple steps:
The 52-week high price of Retension Pharmaceuticals (RTSN) is $. The 52-week low price of Retension Pharmaceuticals (RTSN) is $.
The price-to-earnings (P/E) ratio of Retension Pharmaceuticals (RTSN) is
The price-to-book (P/B) ratio of Retension Pharmaceuticals (RTSN) is 0.00
The dividend yield of Retension Pharmaceuticals (RTSN) is 0.00%
The market capitalization of Retension Pharmaceuticals (RTSN) is
The stock symbol (or ticker) of Retension Pharmaceuticals is RTSN
Consider the share price of Retension Pharmaceuticals as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Retension Pharmaceuticals has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Retension Pharmaceuticals shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Retension Pharmaceuticals stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Retension Pharmaceuticals and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Retension Pharmaceuticals stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied
